A Brain Imaging Study of Opioid (Morphine) and Non-opioid (Ketorolac) Conditioning Effects
NCT01576276 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2018-06-29
Summary
Healthy right-handed volunteers aged 21 to 50 needed for a research study of the effects of morphine and ketorolac on brain activity in response to pain stimuli as measured by functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET). Study will be conducted on six separate days not requiring an overnight stay in the hospital.
Conditions
- Healthy Controls
Interventions
- RADIATION
-
Integrated MR-PET scan
Integrated MR-PET scan using \[11C\]diprenorphine
- DRUG
-
Ketorolac
3 administrations of ketorolac over course of study
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2017-02-28
- Completion
- 2017-02-28
Countries
- United States
Study Locations
More Related Trials
-
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
NCT00887601 ·Status: COMPLETED ·Phase: PHASE1
-
PET/MRI Imaging of Neuraxial Inflammation in Sciatica Patients
NCT02130271 ·Status: COMPLETED
-
Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants
NCT02187627 ·Status: COMPLETED ·Phase: PHASE1
-
Objective Concussion Assessment Using MRI and Metabolomics
NCT05993351 ·Status: RECRUITING
-
18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia
NCT03620552 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases
NCT06731842 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
NCT02079766 ·Status: COMPLETED ·Phase: PHASE2
-
Advanced Imaging Tools in the Study of Mild Traumatic Brain Injury
NCT01044615 ·Status: COMPLETED
-
Neuroimaging Study of Dexmedetomidine-Induced Analgesia
NCT04656470 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assess Fibrin in Brains With AD/ADRD
NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Optimization and Harmonization of Advanced MRI Sequences
NCT06217237 ·Status: COMPLETED
-
Neuraceq™ PET for Detection of Brain Changes in Young Athletes Post-concussion
NCT05270083 ·Status: COMPLETED ·Phase: NA
-
Study of New Magnetic Resonance Imaging Methods of the Brain
NCT00004577 ·Status: RECRUITING
-
Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy
NCT01045044 ·Status: WITHDRAWN
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male Volunteers
NCT00531193 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
NCT04396873 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Optical Pumping Magnetometer Sensors for MagnetoEncephaloGraphy Imaging
NCT04694313 ·Status: COMPLETED ·Phase: NA
-
Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects
NCT01462708 ·Status: COMPLETED ·Phase: PHASE1
-
Positron Emission Tomography of Amyloid in Alzheimer's Disease
NCT00205621 ·Status: SUSPENDED ·Phase: PHASE1
-
Supplementing Neuro-Energy to Aid Cognition
NCT06767124 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
PET Imaging of Peripheral Benzodiazepine Receptors
NCT00696371 ·Status: COMPLETED
-
Longitudinal Study of the Patients With Medication-overuse Headache or Migraine That Completed Baseline MRI
NCT05528081 ·Status: RECRUITING
-
Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects
NCT03082768 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Optimization of Sequences to Improve the Quality and Comfort of the Magnetic Resonance Imaging Examination
NCT05326581 ·Status: RECRUITING